Clearview Capital has closed its latest fund with $325 million in commitments. Atlantic-Pacific Capital served as placement agent for the fund, which was oversubscribed. Clearview specializes in acquiring and recapitalizing North American companies with operating profits of up to $20 million. The firm has a particular interest in manufacturing, specialized services and branded products. Current portfolio companies include Battenfeld Technologies, Pediatric Health Choice and Rowmark.